August 23, 2022
Via: Biopharma DiveAlcon has agreed to acquire Aerie Pharmaceuticals for about $770 million, betting its sprawling commercial presence can boost the uptake of the biotechnology company’s two glaucoma drugs. Alcon, the former eyecare business of Swiss pharmaceutical giant Novartis, will pay $15.25 […]
September 26, 2023
September 21, 2023
September 19, 2023
September 14, 2023
September 7, 2023
September 1, 2023
September 19, 2023
September 5, 2023